These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
810 related articles for article (PubMed ID: 22264569)
21. Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial. Davidson MH; Maki KC; Kalkowski J; Schaefer EJ; Torri SA; Drennan KB J Am Coll Nutr; 1997 Jun; 16(3):236-43. PubMed ID: 9176830 [TBL] [Abstract][Full Text] [Related]
22. Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial. Schuchardt JP; Neubronner J; Kressel G; Merkel M; von Schacky C; Hahn A Prostaglandins Leukot Essent Fatty Acids; 2011 Dec; 85(6):381-6. PubMed ID: 21862301 [TBL] [Abstract][Full Text] [Related]
23. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study. Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375 [TBL] [Abstract][Full Text] [Related]
24. The effect of plant sterols and different low doses of omega-3 fatty acids from fish oil on lipoprotein subclasses. Jacobs DM; Mihaleva VV; van Schalkwijk DB; de Graaf AA; Vervoort J; van Dorsten FA; Ras RT; Demonty I; Trautwein EA; van Duynhoven J Mol Nutr Food Res; 2015 Sep; 59(9):1745-57. PubMed ID: 26019023 [TBL] [Abstract][Full Text] [Related]
25. Omega-3 fatty acids and cardiovascular disease: new developments and applications. Harris WS; Dayspring TD; Moran TJ Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766 [TBL] [Abstract][Full Text] [Related]
26. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels. Berge K; Musa-Veloso K; Harwood M; Hoem N; Burri L Nutr Res; 2014 Feb; 34(2):126-33. PubMed ID: 24461313 [TBL] [Abstract][Full Text] [Related]
27. Prescription omega-3-acid ethyl esters for the treatment of very high triglycerides. Sadovsky R; Kris-Etherton P Postgrad Med; 2009 Jul; 121(4):145-53. PubMed ID: 19641280 [TBL] [Abstract][Full Text] [Related]
28. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. Buckley R; Shewring B; Turner R; Yaqoob P; Minihane AM Br J Nutr; 2004 Sep; 92(3):477-83. PubMed ID: 15469651 [TBL] [Abstract][Full Text] [Related]
29. The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions. Mas E; Woodman RJ; Burke V; Puddey IB; Beilin LJ; Durand T; Mori TA Free Radic Res; 2010 Sep; 44(9):983-90. PubMed ID: 20540666 [TBL] [Abstract][Full Text] [Related]
30. Ethyl EPA and ethyl DHA cause similar and differential changes in plasma lipid concentrations and lipid metabolism in subjects with low-grade chronic inflammation. So J; Asztalos BF; Horvath K; Lamon-Fava S J Clin Lipidol; 2022; 16(6):887-894. PubMed ID: 36522805 [TBL] [Abstract][Full Text] [Related]
32. Eicosapentaenoic acid in serum phospholipids relates to a less atherogenic lipoprotein profile in subjects with familial hypercholesterolemia. Sala-Vila A; Cofán M; Mateo-Gallego R; Cenarro A; Civeira F; Ros E J Nutr Biochem; 2013 Sep; 24(9):1604-8. PubMed ID: 23618530 [TBL] [Abstract][Full Text] [Related]
33. Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Wei MY; Jacobson TA Curr Atheroscler Rep; 2011 Dec; 13(6):474-83. PubMed ID: 21975919 [TBL] [Abstract][Full Text] [Related]
34. Reduction in plasma glucose after lipid changes in mice fed fish oil, docosahexaenoic acid, and eicosapentaenoic acid diets. Higuchi T; Shirai N; Suzuki H Ann Nutr Metab; 2006; 50(2):147-54. PubMed ID: 16391470 [TBL] [Abstract][Full Text] [Related]
35. Beneficial effects of omega-3 fatty acid treatment on the recovery of cardiac function after cold storage of hyperlipidemic rats. Ku K; Oku H; Kaneda T; Onoe M; Zhang Z Metabolism; 1999 Oct; 48(10):1203-9. PubMed ID: 10535379 [TBL] [Abstract][Full Text] [Related]
36. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia. Castro IA; Monteiro VC; Barroso LP; Bertolami MC Nutrition; 2007 Feb; 23(2):127-37. PubMed ID: 17234506 [TBL] [Abstract][Full Text] [Related]
38. The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review. Innes JK; Calder PC Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29425187 [TBL] [Abstract][Full Text] [Related]
39. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options. Weintraub H Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771 [TBL] [Abstract][Full Text] [Related]
40. Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults. Yang ZH; Amar M; Sampson M; Courville AB; Sorokin AV; Gordon SM; Aponte AM; Stagliano M; Playford MP; Fu YP; Yang S; Mehta NN; Remaley AT Nutrients; 2020 Mar; 12(3):. PubMed ID: 32178279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]